RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.

Condition:   Breast Cancer Intervention:   Sponsor:   Pfizer Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials